Listed

Sunshine Biopharma Inc.

SBFMNasdaqCIK 1402328HealthcareFiscal year ends Dec 31

Reports and events: 194 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Sunshine Biopharma Inc., Reports and events
FiledFormWhat it isAccession number
2015-06-0112:56 ET8-K3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws0001354488-15-002794
2015-05-0716:30 ET10-QQuarterly reportPeriod 2015-03-310001354488-15-002193
2015-03-1116:23 ET10-KAnnual reportPeriod 2014-12-310001354488-15-001081
2015-02-2412:43 ET8-K5.02 Departure or appointment of officers or directors0001354488-15-000787
2014-11-1916:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001354488-14-005928
2014-11-1207:00 ET10-QQuarterly reportPeriod 2014-09-300001354488-14-005565
2014-08-1217:26 ET10-QQuarterly reportPeriod 2014-06-300001354488-14-004103
2014-07-0319:07 ETS-1/ARegistration statement, amended0001354488-14-003530
2014-05-2216:47 ETS-1Registration statement0001354488-14-002936
2014-05-0912:46 ET10-QQuarterly reportPeriod 2014-03-310001354488-14-002379
2014-04-2816:34 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001354488-14-002090
2014-03-1916:38 ET10-KAnnual reportPeriod 2013-12-310001354488-14-001275
2013-11-0416:37 ET10-QQuarterly reportPeriod 2013-09-300001354488-13-005974
2013-08-0611:20 ET10-QQuarterly reportPeriod 2013-06-300001354488-13-004212
2013-05-0912:12 ET10-QQuarterly reportPeriod 2013-03-310001354488-13-002516
2013-03-1513:51 ET10-KAnnual reportPeriod 2012-12-310001354488-13-001224
2013-02-2513:23 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001354488-13-000853
2012-11-2914:09 ET8-K8.01 Other events0001354488-12-006249
2012-11-0816:19 ET10-QQuarterly reportPeriod 2012-09-300001354488-12-005637
2012-08-0808:30 ET10-QQuarterly reportPeriod 2012-06-300001354488-12-003912
2012-05-0813:47 ET10-QQuarterly reportPeriod 2012-03-310001354488-12-002208
2012-03-1912:14 ET10-KAnnual reportPeriod 2011-12-310001354488-12-001221
2012-02-0713:27 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001354488-12-000455
2012-02-0314:37 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001354488-12-000414
2011-12-2709:13 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001354488-11-005193
2011-11-0813:50 ET10-QQuarterly reportPeriod 2011-09-300001354488-11-004118
2011-08-0917:11 ET10-QQuarterly reportPeriod 2011-06-300001354488-11-002548
2011-06-1717:01 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001354488-11-001903
2011-05-1214:20 ET10-QQuarterly reportPeriod 2011-03-310001354488-11-001463
2011-03-3017:02 ET10-KAnnual reportPeriod 2010-12-310001013596-11-000008
2011-01-2016:16 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013596-11-000005
2010-11-1211:05 ET10-QQuarterly reportPeriod 2010-09-300001013596-10-000102
2010-08-0418:51 ET10-QQuarterly reportPeriod 2010-06-300001013596-10-000075
2010-06-0318:35 ET8-K3.02 Unregistered sale of equity0001013596-10-000066
2010-04-3012:56 ET10-QQuarterly reportPeriod 2010-03-310001013596-10-000047
2010-01-2215:46 ET8-K5.03 Amendment to articles or bylaws0001013596-10-000004
2010-01-1916:21 ET8-K/A2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013596-10-000003
2009-12-2214:07 ET10-QQuarterly reportPeriod 2009-10-310001013596-09-000044
2009-11-1818:47 ET8-K3.02 Unregistered sale of equity0001013596-09-000036
2009-11-0616:40 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001013596-09-000030
2009-10-3018:16 ET10-KAnnual reportPeriod 2009-07-310001079974-09-000803
2009-10-2020:38 ET8-K2.01 Completion of an acquisition or disposition; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013596-09-000019
2009-06-1516:33 ET10-QQuarterly reportPeriod 2009-04-300001079974-09-000441
2009-03-1613:54 ET10-QQuarterly reportPeriod 2009-01-310001079974-09-000119

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.